SF News Theranos To Lay Off Hundreds And Give Up Blood Testing Following Regulatory Clampdown Elizabeth Holmes, the embattled CEO of blood testing company Theranos announced last night in a letter to company stakeholders that the startup she founded will abandon its core mission and will no longer
SF News Theranos Deathwatch: Feds Ban Elizabeth Holmes From Running Blood Lab For 2 Years In the final episode of this past season of the HBO show Silicon Valley, a character seeking to justify questionable business practices puts it this way: His core product is solid, if some
Arts & Entertainment Jennifer Lawrence To Play Disgraced Theranos CEO Elizabeth Holmes In Upcoming Film In yet another example of Hollywood being obsessed with Silicon Valley lately, a new film is in the works by director/screenwriter Adam McKay (The Big Short, Anchorman) telling the story of the
SF News Forbes: Theranos CEO Elizabeth Holmes Net Worth Now Zero Dollars Elizabeth Holmes, the CEO of blood testing startup Theranos, has had a rough year. News broke in April that the company, which she founded, was under criminal investigation and an SEC probe for
SF News Blood Testing Startup Theranos Is Now Under Criminal Investigation, SEC Probe Federal prosecutors are investigating the possibility that Theranos, Inc., a blood testing startup once valued at $9 billion, misled its investors with regard to its proprietary pin-prick blood sample technology. That was the
SF News CEO Of Healthcare Startup Theranos Faces 2-Year Ban From Blood Testing Biz Theranos founder and chief executive Elizabeth Holmes, a 32-year-old Stanford dropout who claims her aversion to needles led her to invent proprietary blood testing technology requiring just a pin-prick, faces a two-year ban
SF News Health Regulators Investigating Complaints Against Healthcare Startup Theranos From Former Employees Palo Alto-based healthcare technology startup Theranos has been on the defensive since its core blood-sampling technology's capabilities were called into question by a Wall Street Journal article in October. Headed by founder and